Johnson & Johnson Price to Book Ratio 2006-2019 | JNJ

Historical price to book ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current price to book ratio for Johnson & Johnson as of July 16, 2019 is 6.07.
Johnson & Johnson Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2019-07-16 132.50 5.97
2019-03-31 139.79 $22.20 6.30
2018-12-31 128.20 $22.44 5.71
2018-09-30 136.39 $24.09 5.66
2018-06-30 118.99 $23.45 5.07
2018-03-31 124.74 $23.58 5.29
2017-12-31 135.14 $22.43 6.03
2017-09-30 124.99 $27.55 4.54
2017-06-30 126.38 $26.78 4.72
2017-03-31 118.20 $26.10 4.53
2016-12-31 108.63 $26.02 4.18
2016-09-30 110.62 $26.73 4.14
2016-06-30 112.83 $26.47 4.26
2016-03-31 99.94 $26.40 3.79
2015-12-31 94.20 $25.82 3.65
2015-09-30 84.98 $25.86 3.29
2015-06-30 88.03 $25.69 3.43
2015-03-31 90.21 $24.45 3.69
2014-12-31 93.12 $25.06 3.72
2014-09-30 94.31 $27.31 3.45
2014-06-30 91.94 $27.65 3.32
2014-03-31 85.73 $27.08 3.17
2013-12-31 79.36 $26.25 3.02
2013-09-30 74.60 $24.75 3.01
2013-06-30 73.34 $24.75 2.96
2013-03-31 69.12 $23.85 2.90
2012-12-31 58.96 $23.33 2.53
2012-09-30 57.45 $23.08 2.49
2012-06-30 55.82 $21.97 2.54
2012-03-31 53.98 $22.35 2.42
2011-12-31 53.20 $20.95 2.54
2011-09-30 51.19 $22.52 2.27
2011-06-30 52.99 $22.67 2.34
2011-03-31 46.79 $21.86 2.14
2010-12-31 48.41 $20.66 2.34
2010-09-30 48.08 $20.85 2.31
2010-06-30 45.40 $19.19 2.37
2010-03-31 49.67 $19.19 2.59
2009-12-31 48.69 $18.37 2.65
2009-09-30 45.67 $18.27 2.50
2009-06-30 42.26 $16.79 2.52
2009-03-31 38.79 $15.87 2.44
2008-12-31 43.76 $15.35 2.85
2008-09-30 50.27 $16.45 3.06
2008-06-30 46.39 $16.61 2.79
2008-03-31 46.44 $16.19 2.87
2007-12-31 47.44 $15.25 3.11
2007-09-30 46.44 $15.17 3.06
2007-06-30 43.27 $14.90 2.90
2007-03-31 42.04 $14.14 2.97
2006-12-31 45.79 $13.59 3.37
2006-09-30 44.79 $13.97 3.21
2006-06-30 41.09 $13.89 2.96
2006-03-31 40.36 $13.83 2.92
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $357.663B $81.581B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $237.687B 13.88
Roche Holding AG (RHHBY) Switzerland $229.260B 0.00
Merck (MRK) United States $208.443B 17.95
Novartis AG (NVS) Switzerland $204.812B 17.82
Novo Nordisk (NVO) Denmark $116.736B 19.37
Eli Lilly (LLY) United States $105.306B 19.54
Sanofi (SNY) France $103.972B 12.81
AbbVie (ABBV) United States $103.882B 8.59
AstraZeneca (AZN) United Kingdom $101.873B 11.73
GlaxoSmithKline (GSK) United Kingdom $101.456B 12.86
Bristol-Myers Squibb (BMY) United States $72.282B 10.67
Bayer (BAYRY) Germany $63.746B 9.29
H Lundbeck (HLUYY) Denmark $7.717B 11.14